The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells

ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE

Anders Waage, Alfred Halstensen, Terje Espevik · The Lancet · 1987 · 1.1K citations

Inflammation, Clinical Epidemiology, Immunology +4

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

K. Ohlsson, P. Björk, Magnus Bergenfeldt et al. · Nature · 1990 · 855 citations

Inflammation, Cytokine, Immunology +6

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline

Robert M. Strieter, Daniel G. Remick, P A Ward et al. · Biochemical and Biophysical Research Communications · 1988 · 559 citations

Inflammation, Molecular Regulation, Apoptosis +9

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

H. Wachtel · Neuropharmacology · 1983 · 243 citations

Molecular Pharmacology, Psychiatry, Medicine +9

Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.

Stefan Endres, H.-J. Fülle, Bhanu Sinha et al. · PubMed · 1991 · 239 citations

Immunology, Immune Regulation, Cell Death +21